[Google Scholar] 401.Moon M.J., Park S., Kim D.K., Cho E.B., Hwang J.I., Vaudry H
This excipient, glycerol monocaprylocaprate, is known to act both as a solubilizer and a mild intestinal permeation enhancer, justifying its selection as the main lipid phase of the LBF ( Among the tested surfactants, Kolliphor RH40 allowed the formation of stable emulsions at low concentration (10%), with monodispersed droplets measuring approximately 100 nm (formulation F9)
So our hypothesis is around neuroinflammation, but defined in a way where you could say it's both peripheral inflammation and the effect it has on the vasculature, it's the effect on the blood-brain barrier
Pricing is published on the brand's site and changes over time